MLL1-IN-1 is an orally active MLL1 inhibitor with an IC50 of 0.043 µM. MLL1-IN-1 induces Menin protein degradation and inhibits the proliferation of leukemia cells. MLL1-IN-1 can induce tumor regression in leukemia-bearing mice. MLL1-IN-1 is useful for research into MLL1-associated leukemia[1].
Molecular Weight:
589.74
CAS Number:
[3058433-50-1]
Formula:
C34H44FN5O3
Target:
Histone Methyltransferase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted